Renalytix Plc (RNLXY)
OTCMKTS · Delayed Price · Currency is USD
0.1900
-0.0090 (-4.52%)
Nov 17, 2025, 4:00 PM EST
Renalytix Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2018 - 2020 |
| 3 | 2.3 | 3.4 | 2.97 | 1.49 | Upgrade | |
Revenue Growth (YoY) | 30.44% | -32.41% | 14.58% | 99.19% | - | Upgrade |
Cost of Revenue | 1.8 | 2.1 | 2.68 | 2.1 | 0.86 | Upgrade |
Gross Profit | 1.2 | 0.2 | 0.72 | 0.87 | 0.63 | Upgrade |
Selling, General & Admin | 17.3 | 23.4 | 28.66 | 39.52 | 23.48 | Upgrade |
Research & Development | 0.9 | 5.1 | 14.3 | 14.65 | 10.04 | Upgrade |
Operating Expenses | 18.2 | 30.5 | 42.96 | 54.17 | 33.52 | Upgrade |
Operating Income | -17 | -30.3 | -42.24 | -53.3 | -32.89 | Upgrade |
Interest Expense | -0.5 | - | - | - | - | Upgrade |
Interest & Investment Income | - | 0.2 | 0.1 | 0.01 | 0.2 | Upgrade |
Earnings From Equity Investments | - | - | -0.01 | 0.01 | -2.11 | Upgrade |
Currency Exchange Gain (Loss) | 0.3 | -0.5 | 0.36 | 9.69 | -8.77 | Upgrade |
Other Non Operating Income (Expenses) | -0.1 | - | 0.36 | 0.12 | 1.41 | Upgrade |
EBT Excluding Unusual Items | -17.3 | -30.6 | -41.44 | -43.46 | -42.17 | Upgrade |
Gain (Loss) on Sale of Investments | -0.6 | -0.6 | -1.08 | -5.9 | 6.48 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.05 | Upgrade |
Asset Writedown | - | -10.5 | - | - | - | Upgrade |
Other Unusual Items | -3.9 | -3.8 | -3.09 | 4.11 | 0.3 | Upgrade |
Pretax Income | -21.8 | -45.5 | -45.61 | -45.25 | -35.34 | Upgrade |
Income Tax Expense | -1.4 | - | 0 | 0.03 | - | Upgrade |
Earnings From Continuing Operations | -20.4 | -45.5 | -45.61 | -45.28 | -35.34 | Upgrade |
Minority Interest in Earnings | - | - | - | - | 0.61 | Upgrade |
Net Income | -20.4 | -45.5 | -45.61 | -45.28 | -34.73 | Upgrade |
Net Income to Common | -20.4 | -45.5 | -45.61 | -45.28 | -34.73 | Upgrade |
Shares Outstanding (Basic) | 275 | 108 | 82 | 73 | 71 | Upgrade |
Shares Outstanding (Diluted) | 275 | 108 | 82 | 74 | 71 | Upgrade |
Shares Change (YoY) | 153.82% | 31.59% | 11.34% | 3.29% | 21.00% | Upgrade |
EPS (Basic) | -0.07 | -0.42 | -0.55 | -0.62 | -0.49 | Upgrade |
EPS (Diluted) | -0.07 | -0.42 | -0.55 | -0.67 | -0.49 | Upgrade |
Free Cash Flow | -17.9 | -29.8 | -34.09 | -46.48 | -29.17 | Upgrade |
Free Cash Flow Per Share | -0.07 | -0.28 | -0.41 | -0.63 | -0.41 | Upgrade |
Gross Margin | 40.00% | 8.70% | 21.16% | 29.43% | 42.45% | Upgrade |
Operating Margin | -566.67% | -1317.39% | -1241.26% | -1794.55% | -2205.63% | Upgrade |
Profit Margin | -680.00% | -1978.26% | -1340.20% | -1524.44% | -2328.97% | Upgrade |
Free Cash Flow Margin | -596.67% | -1295.65% | -1001.62% | -1565.02% | -1956.54% | Upgrade |
EBITDA | -16.8 | -30.1 | -41.93 | -53.01 | -32.69 | Upgrade |
D&A For EBITDA | 0.2 | 0.2 | 0.31 | 0.29 | 0.2 | Upgrade |
EBIT | -17 | -30.3 | -42.24 | -53.3 | -32.89 | Upgrade |
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.